Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Multiple sclerosis | D009103 | EFO_0003885 | G35 | — | 2 | — | — | — | 2 |
Relapsing-remitting multiple sclerosis | D020529 | EFO_0003929 | — | — | 2 | — | — | — | 2 |
Sclerosis | D012598 | — | — | — | 2 | — | — | — | 2 |
Ulcerative colitis | D003093 | EFO_0000729 | K51 | — | 2 | — | — | — | 2 |
Colitis | D003092 | EFO_0003872 | K52.9 | — | 2 | — | — | — | 2 |
Ulcer | D014456 | MPATH_579 | — | — | 2 | — | — | — | 2 |
Drug common name | Vatelizumab |
INN | vatelizumab |
Description | Vatelizumab (humanized mab) |
Classification | Antibody |
Drug class | monoclonal antibodies |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | CHEMBL1743086 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | A4R7G50030 (ChemIDplus, GSRS) |